Literature DB >> 11076137

Injury severity and neuropsychological and balance outcomes of four college athletes.

M Mrazik1, M S Ferrara, C L Peterson, R E Elliott, R W Courson, M D Clanton, G W Hynd.   

Abstract

Recent evidence suggests significant short-term neurocognitive deficits following mild traumatic brain injury (MTBI) in sports. However, sequelae of mild head injuries is complicated by many factors including a history of multiple head injuries and injury severity. Few studies have considered the influence these variables may have on proper classification of a MTBI and their meaning for return-to-play guidelines. This study presents the short-term neuropsychological and balance outcomes of four college athletes who sustained mild head injuries of different severity (grade I, grade II, grade III and multiple head injured with a grade II based on American Academy of Neurology guidelines). The results demonstrated that self-report symptoms of concussion were slow to resolve in the grade III and multiple concussed individuals. For neuropsychological testing, Trails A & B, Symbol Digit Modalities Test and Digits Span Backwards were the most sensitive in identifying differences between the injuries. For balance assessments using the Neurocom Smart Balance System, the Sensory Organization Test and Reaction Time were also important variables in detecting differences among the various injuries. When these data are used together, it can assist physicians in determining safe return-to-play for athletes who sustain MTBI. There are contradindications in the numerous grading systems and return-to-play guidelines for MTBI. The results from this study provides new evidence which can be assimilated into a valid grading scale for MTBI sustained in sport.

Entities:  

Mesh:

Year:  2000        PMID: 11076137     DOI: 10.1080/026990500445736

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  7 in total

Review 1.  A nonlinear dynamic approach for evaluating postural control: new directions for the management of sport-related cerebral concussion.

Authors:  James T Cavanaugh; Kevin M Guskiewicz; Nicholas Stergiou
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

2.  Cognitive task effects on gait stability following concussion.

Authors:  Robert D Catena; Paul van Donkelaar; Li-Shan Chou
Journal:  Exp Brain Res       Date:  2006-07-07       Impact factor: 1.972

Review 3.  Summary and agreement statement of the 2nd International Conference on Concussion in Sport, Prague 2004.

Authors:  P McCrory; K Johnston; W Meeuwisse; M Aubry; R Cantu; J Dvorak; T Graf-Baumann; J Kelly; M Lovell; P Schamasch
Journal:  Br J Sports Med       Date:  2005-04       Impact factor: 13.800

4.  Concussion symptom inventory: an empirically derived scale for monitoring resolution of symptoms following sport-related concussion.

Authors:  Christopher Randolph; Scott Millis; William B Barr; Michael McCrea; Kevin M Guskiewicz; Thomas A Hammeke; James P Kelly
Journal:  Arch Clin Neuropsychol       Date:  2009-06-23       Impact factor: 2.813

5.  Shannon and Renyi entropies to classify effects of Mild Traumatic Brain Injury on postural sway.

Authors:  Jianbo Gao; Jing Hu; Thomas Buckley; Keith White; Chris Hass
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

6.  Individual Baseline Balance Assessments in a Large Sample of Incoming NCAA Division I Athletes Using a Force Plate System.

Authors:  Scott A Weismiller; Robert Monaco; Jason Womack; Brandon Alderman; Carrie Esopenko; Fiona N Conway; Kyle Brostrand; Allison Brown; Nicola L de Souza; Jennifer F Buckman
Journal:  Int J Sports Phys Ther       Date:  2021-02-01

7.  Dynamic Visual Stimulations Produced in a Controlled Virtual Reality Environment Reveals Long-Lasting Postural Deficits in Children With Mild Traumatic Brain Injury.

Authors:  Thomas Romeas; Selma Greffou; Remy Allard; Robert Forget; Michelle McKerral; Jocelyn Faubert; Isabelle Gagnon
Journal:  Front Neurol       Date:  2021-11-25       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.